Medidata CTMS to support QCTR clinical operations
Medidata CTMS is expected to help in the reduction of time and effort that is required for tracking key milestones and operational metrics throughout their clinical studies and
Vertex Pharmaceuticals and Genomics have agreed a four-year extension to their drug discovery partnership in a deal with a potential value exceeding $220m.